M/s. Bafna Pharmaceuticals Limited was admitted into Corporate Insolvency Resolution Process (CIRP) by NCLT, Chennai Bench. A resolution plan was approved by NCLT and affirmed by NCLAT. The Civil Appeal filed before the Supreme Court challenging the approval was dismissed.
M/s. Bafna Pharmaceuticals Limited was admitted into CIRP by NCLT, Chennai Bench.
A resolution plan was approved by NCLT and affirmed by NCLAT.
The Supreme Court dismissed the Civil Appeal challenging the approval of the resolution plan.
The petitioner challenges the recovery notice issued by the respondent.
The respondent contended that the EPFO was not a party before the NCLT and that the Approved Resolution Plan does not bind statutory authorities.
The petitioner submitted that the dues sought to be recovered were not part of the claims lodged before the Resolution Professional and were not provided for in the Approved Resolution Plan.
…Sign in to view the parties.
M/s. Bafna Pharmaceuticals Limited was admitted…
A Resolution Plan was subsequently approved by…
M/s. Bafna Pharmaceuticals Limited was admitted into Corporate Insolvency Resolution Process (CIRP) by NCLT, Chennai Bench. A resolution plan was approved by NCLT and affirmed by NCLAT. The Civil Appeal filed before the Supreme Court challenging the approval was dismissed.
M/s. Bafna Pharmaceuticals Limited was admitted into CIRP by NCLT, Chennai Bench.
A resolution plan was approved by NCLT and affirmed by NCLAT.
The Supreme Court dismissed the Civil Appeal challenging the approval of the resolution plan.
The petitioner challenges the recovery notice issued by the respondent.
The respondent contended that the EPFO was not a party before the NCLT and that the Approved Resolution Plan does not bind statutory authorities.
The petitioner submitted that the dues sought to be recovered were not part of the claims lodged before the Resolution Professional and were not provided for in the Approved Resolution Plan.
…M/s. Bafna Pharmaceuticals Limited was admitted…
A Resolution Plan was subsequently approved by…